Clinical Trial Update: A Phase 1b Study of Lonitoclax + Azacitidine in Acute Myeloid Leukemia Patients [Phase 1]

View source ↗

Summary

This document announces a Phase 1b trial of Lonitoclax in combination with azacitidine for Acute Myeloid Leukemia, and the study is currently not yet recruiting…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• AZACITIDINE (AZACITIDINE)
• Lonitoclax (lonitoclax)

Snippet

Sponsor: Lomond Therapeutics Holdings, Inc. | Conditions: Acute Myeloid Leukemia | Phase 1 | Status: NOT_YET_RECRUITING